1004757-96-3
1004757-96-3 structure
- Name: BMS-741672
- Chemical Name: N-{(1R,2S,5R)-5-[Isopropyl(methyl)amino]-2-[(3S)-2-oxo-3-{[6-(trifluoromethyl)-4-quinazolinyl]amino}-1-pyrrolidinyl]cyclohexyl}acetamide
- CAS Number: 1004757-96-3
- Molecular Formula: C25H33F3N6O2
- Molecular Weight: 506.564
- Create Date: 2020-01-11 20:07:51
- Modify Date: 2025-08-25 13:17:42
-
BMS-741672 is a potent, selective CCR2 antagonist for the treatment of neuropathic pain. Diabetes Phase 2 Clinical
| Name | N-{(1R,2S,5R)-5-[Isopropyl(methyl)amino]-2-[(3S)-2-oxo-3-{[6-(trifluoromethyl)-4-quinazolinyl]amino}-1-pyrrolidinyl]cyclohexyl}acetamide |
|---|---|
| Synonyms |
Acetamide, N-[(1R,2S,5R)-5-[methyl(1-methylethyl)amino]-2-[(3S)-2-oxo-3-[[6-(trifluoromethyl)-4-quinazolinyl]amino]-1-pyrrolidinyl]cyclohexyl]-
MFCD30829467 N-{(1R,2S,5R)-5-[Isopropyl(methyl)amino]-2-[(3S)-2-oxo-3-{[6-(trifluoromethyl)-4-quinazolinyl]amino}-1-pyrrolidinyl]cyclohexyl}acetamide |
| Description | BMS-741672 is a potent, selective CCR2 antagonist for the treatment of neuropathic pain. Diabetes Phase 2 Clinical |
|---|---|
| References | References 1. Joerg Deerberg, et al. Org. Process Res. Dev., 2016, 20 (11), pp 1949-1966. View Related Products by Target Chemokine Receptor (CCR and CXCR) Diabetes |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 695.4±55.0 °C at 760 mmHg |
| Molecular Formula | C25H33F3N6O2 |
| Molecular Weight | 506.564 |
| Flash Point | 374.3±31.5 °C |
| Exact Mass | 506.261719 |
| LogP | 1.64 |
| Vapour Pressure | 0.0±2.2 mmHg at 25°C |
| Index of Refraction | 1.585 |